Gilead Sciences Gains for Eight Straight Session (NASDAQ:GILD)


The maker of the experimental coronavirus drug Remdesivir, Gilead Sciences. Inc., reports positive results from trials

Justin Sullivan/Getty Images News

Gilead Sciences (NASDAQ:FIX) shares continue to rise for the eighth straight session as the stock rose 1.5% on Monday.

The biopharmaceutical firm has added 4.5% over the previous seven sessions. The stock is up more than 15% this year, compared with gains of more than 26%.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *